Official recall notice

FDA DrugClass INotable

Cefazolin in Dextrose Injection Recall (Jul 2026) – Baxter

Product: Cefazolin in Dextrose Injection; Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-3508-41.

Recall date
2026-07-24
Brand
Baxter
Category
Drug
FDA class
Class I

Why it was recalled

Hazard

Particulate matter (cardboard) found in the solution.

One email a week when there are new recalls. Confirm by email; unsubscribe anytime.

Product description

Particulate matter (cardboard) found in the solution.

Affected products

Lot # LD175708, Exp Date: 14-Feb-2027.

Verify with the official notice →
Share:

Related Recalls

2026-08-26 · FDA_DRUG
FDA Recall: Baxter: 0.9% Sodium Chloride Injection, USP, 500 mL VIAFLEX Plastic Container
Baxter
2026-08-26 · FDA_DRUG
FDA Recall: Baxter: 0.9% Sodium Chloride Injection, USP, 500 mL VIAFLEX Plastic Container
Baxter
2026-08-25 · FDA_DRUG
FDA Recall: Baxter: 70% Dextrose Injection, USP in 2000 mL VIAFLEX Plastic Container
Baxter
2026-08-25 · FDA_DRUG
FDA Recall: Baxter: Anticoagulant Sodium Citrate Solution USP, 250 mL VIAFLEX Plastic Container
Baxter